Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 


Related Products

Hot Products

Basic Information post buying leads Suppliers


CAS No. 191732-72-6 Density 1.46 g/cm3
Solubility Melting Point 269-271 °C
Formula C13H13N3O3 Boiling Point 614 °C at 760 mmHg
Molecular Weight 259.26 Flash Point 325.1 °C
Transport Information Appearance yellow solid
Safety Risk Codes
Molecular Structure Molecular Structure of 191732-72-6 (Lenalidomide) Hazard Symbols

Lenalidomide(other anti-cancers);Revlimid (lenalidomide);Revlimid (lenalidomide)/191732-72-6;Lenalidomide ;3-(7-Amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione;Revlimid;


Lenalidomide Specification

1. Introduction of Lenalidomide
Lenalidomide is one kind of yellow solid or powder. The IUPAC Name of this chemical is 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione. Besides, Lenalidomide belongs to Molecular Targeted Antineoplastic; Intermediates & Fine Chemicals; Pharmaceuticals. Its Classification Code is Antineoplastic Agents; Immunomulator intended for use in the treatment of multiple myeloma, myelodysplastic syndromes, solid tumors including glioma and metastatic melanoma, Crohn's disease, and heart failure. Lenalidomide is soluble in organic solvent/water mixtures, and buffered aqueous solvents.

2. Properties of Lenalidomide
Physical properties about Lenalidomide are:
(1)Melting Point: 269-271°C; (2)Boiling point: 614 °C at 760 mmHg; (3)Flash Point: 325.1 °C; (4)Density: 1.46 g/cm3; (5)Index of Refraction: 1.672; (6)Molar Refractivity: 66.45 cm3;(7)Molar Volume: 177.4 cm3; (8)Surface Tension: 73.2 dyne/cm; (9)Enthalpy of Vaporization: 91.11 kJ/mol; (10)Vapour Pressure: 5.2E-15 mmHg at 25°C; (11)XLogP3-AA: -0.5; (12)H-Bond Donor: 2; (13)H-Bond Acceptor: 4; (14)Rotatable Bond Count: 1; (15)Tautomer Count: 8; (16)Exact Mass: 259.095691; (17)MonoIsotopic Mass: 259.095691; (18)Topological Polar Surface Area: 92.5; (19)Heavy Atom Count: 19; (20)Formal Charge: 0; (21)Complexity: 437; (22)Isotope Atom Count: 0; (23)Defined Atom Stereocenter Count: 0; (24)Undefined Atom Stereocenter Count: 1; (25)Defined Bond Stereocenter Count: 0; (26)Undefined Bond Stereocenter Count: 0; (27)Covalently-Bonded Unit Count: 1; (28)Feature 3D Acceptor Count: 3; (29)Feature 3D Donor Count: 2; (30)Feature 3D Cation Count: 1; (31)Feature 3D Ring Count: 3; (32)Effective Rotor Count: 2.2; (33)Conformer Sampling RMSD: 0.6.

3. Structure Descriptors of Lenalidomide
(1)Canonical SMILES: C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
(2)InChI: InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)  
(4)Smiles: N1C([C@@H](CCC1=O)N1C(c2cccc(c2C1)N)=O)=O

4. Uses of Lenalidomide
Lenalidomide (CAS NO.191732-72-6) is used for immunomodulatory drug, analog of THALIDOMIDE. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes.

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields